DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sulfamylon (Mafenide Acetate Topical) - Published Studies

 
 



Sulfamylon Related Published Studies

Well-designed clinical trials possibly related to Sulfamylon (Mafenide Topical)

A prospective double-blinded comparative analysis of framycetin and silver sulphadiazine as topical agents for burns: a pilot study. [2009.08]

A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study. [2007.09]

Other research related to Sulfamylon (Mafenide Topical)

Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant? [2010.02]

Allergic contact dermatitis to mafenide acetate: a case series and review of the literature. [2007.08]

Topical Sulfamylon cream inhibits DNA and protein synthesis in the skin donor site wound. [2006.05]

Mafenide acetate allergy presenting as recurrent chondritis. [2002.02]

Off-label drug use in WOC nursing: issues related to use of mafenide acetate to treat infected chronic wounds. [2001.09]

Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue. [2001.07]

Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? Assessment by two topical antimicrobial test assay systems. [2001.07]

The use of 5% mafenide acetate solution in the postgraft treatment of necrotizing fasciitis. [2001.01]

Topical sulfamylon reduces engraftment of cultured skin substitutes on athymic mice. [1999.01]

Serious silver sulphadiazine and mafenide acetate dermatitis. [1995.06]

Five percent mafenide acetate solution in the treatment of thermal injuries. [1993.03]

Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds. [1991.02]

Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns. [1988.11]

Mafenide-induced pseudochondritis. [1988.03]

Mafenide acetate concentrations and bacteriostasis in experimental burn wounds treated with a three-layered laminated mafenide-saline dressing. [1980.10]

Other possibly related research studies

Survival benefit conferred by topical antimicrobial preparations in burn patients: a historical perspective. [2004.04]

An in vivo comparison of topical agents on wound repair. [2001.09.01]

Efficacy of topical silver against fungal burn wound pathogens. [1999.08]

The use of a modified Dakin's solution (sodium hypochlorite) in the treatment of Vibrio vulnificus infection. [1999.03]

Beneficial effect of Aloe on wound healing in an excisional wound model. [1996.06]

In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods. [1997.09]

Treatment of a severe alkali burn. [1996.03]

Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. [1994.09]

Risk of aluminum accumulation in patients with burns and ways to reduce it. [1994.07]

Inhibition of wound contraction by topical antimicrobials. [1993.04]

Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care. [1993.03]

Review of the use of povidone-iodine (PVP-I) in the treatment of burns. [1993]

Burn of the auricle. [1992.05]

Effects of topical antimicrobial agents on the human neutrophil respiratory burst. [1991.05]

Preventing postoperative burn wound aspergillosis. [1991.03]

Fungal burn wound infection. A 10-year experience. [1991.01]

The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. [1989.11]

Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound. [1988.04]

Comparison of battlefield-expedient topical antimicrobial agents for the prevention of burn wound sepsis in a rat model. [2005.07]

Topical treatment of pediatric patients with burns: a practical guide. [2002]

A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. [2000.03]

Current treatment recommendations for topical burn therapy. [1990.09]

Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci. [1990.09]

Analysis of infection in a burn ward. [1989.10]

A comparison of Biobrane vs. homograft for coverage of contaminated burn wounds. [1988.10]

Burn care standards in Israel: lack of consensus. [2005.11]

Managing extracavitary prosthetic vascular graft infections: a pathway to success. [2006.12]

[The antibacterial effect of cecropin B on pseudomonas aeruginosa infection of wounds in mice] [2006.12]

Seven years' experience with Integra as a reconstructive tool. [2007.01]

Management of bioburden with a burn gel that targets nociceptors. [2007.04]

A Silver-Coated Antimicrobial Barrier Dressing Used Postoperatively on Meshed Autografts: A Dressing Comparison Study. [2007.07.25]

Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial. [2007.07]

Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes. [2008.05]

Understanding and managing burn pain: Part 2. [2009.05]

Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics? [2009.01]

Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. [2010.09]

Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties. [2009.10]

Suprathel-antiseptic matrix: in vitro model for local antiseptic treatment? [2011.02]

The diversity of wound presentation associated with freon contact frostbite injury. [2010.09]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017